Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuji, S.
Right arrow Articles by Kuroiwa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuji, S.
Right arrow Articles by Kuroiwa, Y.
NEUROLOGY 1983;33:1503
© 1983 American Academy of Neurology

Creutzfeldt-Jakob disease in Japan

Sadatoshi Tsuji, MD and Yoshigoro Kuroiwa, MD

Department of Neurology, Neurological Institute, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

In a nationwide survey of Creutzfeldt-Jakob disease (CJD) in Japan, the point prevalence rate on June 1, 1978 in Fukuoka Prefecture and the estimated national prevalence rate were approximately one per one million population. The minimal period prevalence rate was 0.45 per one million population. The minimal annual incidence and the minimal annual mortality rate were 0.19 and 0.15 per one million population, respectively. The geographic distribution of CJD in Japan was uniform. Clinically, CJD affected the central nervous system diffusely and was rapidly fatal. No specific features were found in family, social, and past histories.

Address correspondence and reprint requests to Dr. Tsuji, Department of Neurology. Neurological Institute, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi. Higashi-Ku, Fukuoka City 812, Japan.

Accepted for publication February 23, 1983.




This article has been cited by other articles:


Home page
 NeurologyHome page
G. D. Rabinovici, P. N. Wang, J. Levin, L. Cook, M. Pravdin, J. Davis, S. J. DeArmond, N. M. Barbaro, J. Martindale, B. L. Miller, et al.
First symptom in sporadic Creutzfeldt-Jakob disease
Neurology, January 24, 2006; 66(2): 286 - 287.
[Full Text] [PDF]

Home page
 NeurologyHome page
S. Collins, A. Boyd, J. S. Lee, V. Lewis, A. Fletcher, C. A. McLean, M. Law, J. Kaldor, M. J. Smith, and C. L. Masters
Creutzfeldt-Jakob disease in Australia 1970-1999
Neurology, November 12, 2002; 59(9): 1365 - 1371.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
C. E. M. Hillier and R. L. Salmon
Is there evidence for exogenous risk factors in the aetiology and spread of Creutzfeldt-Jakob disease?
QJM, September 1, 2000; 93(9): 617 - 631.
[Full Text] [PDF]

Home page
 Arch NeurolHome page
B. B. Worrall, L. P. Rowland, S. S.-M. Chin, and J. A. Mastrianni
Amyotrophy in Prion Diseases
Arch Neurol, January 1, 2000; 57(1): 33 - 38.
[Abstract] [Full Text] [PDF]